1. Home
  2. SONO vs BHVN Comparison

SONO vs BHVN Comparison

Compare SONO & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sonos Inc.

SONO

Sonos Inc.

N/A

Current Price

$17.79

Market Cap

1.8B

ML Signal

N/A

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

N/A

Current Price

$13.20

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SONO
BHVN
Founded
2002
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Video Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.1B
IPO Year
2018
2022

Fundamental Metrics

Financial Performance
Metric
SONO
BHVN
Price
$17.79
$13.20
Analyst Decision
Buy
Buy
Analyst Count
4
17
Target Price
$18.63
★ $21.27
AVG Volume (30 Days)
1.6M
★ 2.7M
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 26.08
EPS
★ 0.77
N/A
Revenue
★ $1,443,276,000.00
N/A
Revenue This Year
$6.89
N/A
Revenue Next Year
$5.65
N/A
P/E Ratio
$23.06
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$12.44
$7.48
52 Week High
$19.82
$18.57

Technical Indicators

Market Signals
Indicator
SONO
BHVN
Relative Strength Index (RSI) 64.88 47.35
Support Level $14.11 $8.43
Resistance Level $18.66 $14.01
Average True Range (ATR) 0.57 0.83
MACD 0.20 0.00
Stochastic Oscillator 88.73 50.16

Price Performance

Historical Comparison
SONO
BHVN

About SONO Sonos Inc.

Sonos Inc is an audio company dedicated to elevating life through sound, offering a connected platform that brings together music, movies, stories, and conversations. Its portfolio includes home theater speakers, components, plug-in and portable speakers and headphones, known for exceptional sound, thoughtful design, ease of use and seamless access to audio content. Its partner products and other revenue categories include accessories for home integration, such as custom-designed stands, mounts, and shelving units, along with partnerships for architectural speakers and automotive sound systems, as well as licensing, advertising revenue, and subscription-based services. The company operates in the United States and other countries, with the majority of revenue coming from the United States.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Share on Social Networks: